Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
about
An overview of disparities and interventions in pediatric kidney transplantation worldwideEvaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosusChronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus.Differences in disease phenotype and severity in SLE across age groups.Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literatureIncreased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosusAssociation of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis.Cardiovascular risk in pediatric-onset rheumatological diseases.International validation of a urinary biomarker panel for identification of active lupus nephritis in children.Urine biomarkers in juvenile-onset SLE nephritis.The treatment of systemic lupus proliferative nephritis.The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study.New insights into the pathogenesis and management of lupus in children.Why are kids with lupus at an increased risk of cardiovascular disease?Management considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy.Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis.Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.Signal transducer and activator of transcription 5 is implicated in disease activity in adult and juvenile onset systemic lupus erythematosus.Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults With Systemic Lupus Erythematosus.Relationship between health-related quality of life, disease activity and disease damage in a prospective international multicenter cohort of childhood onset systemic lupus erythematosus patients.The vascular phenotype of children with systemic lupus erythematosus.Transition of Care and Health-Related Outcomes in Pediatric-Onset Systemic Lupus Erythematosus.Childhood lupus nephritis in a developing country-24 years' single-center experience from North India.Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.Dissecting the damage in Northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study.The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort.Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus.Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial.Systemic lupus erythematosus: not just a rash.Appearance concern and depression in adolescent girls with systemic lupus erythematous.Inter-observer variability of the histological classification of lupus glomerulonephritis in children.Systemic lupus erythematosus and ocular involvement: an overview.Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study.The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE.Children and adolescents with SLE: not just little adults.Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.
P2860
Q26851550-C35EC4B0-4325-46D7-9F33-DDDE63522BA1Q31121775-3E1C1AD4-60CC-4C78-BBCC-A89C0D5510DFQ33425025-EF0A47C8-22B4-4D51-ABBB-BE1C3B7B219CQ33431990-5339D431-74A3-4FBA-BE5C-ADD24CEB7F3EQ34937950-A1CDB7CD-F21C-4114-91A5-15BCFB1EE6D3Q35426946-A8F109A5-15E7-4B18-99D2-B2663002846BQ36375184-4026F390-A96A-43DD-9962-B178EA59FA0BQ36903089-919599BC-8FCF-4387-A767-C37097C290B1Q37547407-448B175D-6DFC-4C23-8B2D-DB910F8154A3Q38010347-00A7D096-8A9C-4D00-A98D-DE7DCB321525Q38062341-9A1E0F76-904C-45BE-B378-362B6374305EQ38130647-C5963F96-698F-42F6-9962-107FB2E06CCDQ38163393-288744A7-4490-4B61-B27F-A334C4A58CCDQ38192577-5E27E10C-29A8-4E55-838F-9C54CEF98B4FQ38591752-43C4DA14-ACE7-4722-A3F1-FCEE5107AF83Q38640910-FC45F588-37E9-4248-B92A-8C174CE2E27FQ38771936-642CDDB9-2DE0-4435-B98C-484209721F05Q38865389-519E96A9-9B32-48BB-BA23-16496964DB80Q39053375-9F8FE9C5-2BA7-4B4A-9785-26CE331BD62AQ39178596-1F6075DF-25E8-47A9-8499-3AFB6F6E32F4Q39246970-0A328A09-0130-40AA-9FE9-ED0316D3C7C8Q39282087-D914B18E-9C8D-4190-A4AB-94D21DB6C491Q40633158-DBF632D3-0620-44EB-BEE5-5C60FF1416AEQ40910621-F8F343D2-56DE-4B56-B5F7-9370650ABF6EQ40978743-08CF968D-5BE4-46C3-9C6F-BAF880E97853Q41355973-8B72A412-33A4-41CC-B7C2-DA350F54462FQ42632915-7D96AEB2-89F7-48CC-B3B2-D78D04FCA8BDQ44581884-6A7CEDB1-CA03-4BEE-972D-9172774CA8E4Q44723933-15C3F93F-C18D-48DE-9722-805B1450673FQ47683243-39C70821-90B7-4C21-AF5B-A8519010BA56Q48067858-AAF6E8A3-221B-49E0-B5C5-174304EFEBE3Q48276733-613DCC62-0ADB-4840-A231-79A087CD57AFQ48615130-B775C839-0A45-4D82-9FA4-867710976522Q48654210-0CB4F988-E405-43E7-838E-4AE42F64BFB5Q49833678-50108E88-3F8E-4D19-BA50-1B27F242FD22Q50231899-08430EBE-2A4B-498A-83C9-A2F08DD0046EQ50285114-170E8C6A-1ECF-40A8-A99A-963079B87D8BQ51121176-326C36C4-8380-4B93-848C-CD0CA7C9DEFDQ51196776-1F4EF77A-82CE-4789-8FDF-49DC9E952073Q52353641-9572FE4B-EB65-4D30-A814-27B1FDC3CBA1
P2860
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Disease activity, severity, an ...... ic Lupus Erythematosus Cohort.
@en
Disease activity, severity, an ...... ic Lupus Erythematosus Cohort.
@nl
type
label
Disease activity, severity, an ...... ic Lupus Erythematosus Cohort.
@en
Disease activity, severity, an ...... ic Lupus Erythematosus Cohort.
@nl
prefLabel
Disease activity, severity, an ...... ic Lupus Erythematosus Cohort.
@en
Disease activity, severity, an ...... ic Lupus Erythematosus Cohort.
@nl
P2093
P2860
P356
P1476
Disease activity, severity, an ...... ic Lupus Erythematosus Cohort.
@en
P2093
Clarissa Pilkington
Eileen M Baildam
Gavin Cleary
Jane Tizard
Janet E McDonagh
Janet Gardner-Medwin
Joyce Davidson
Kate Armon
Kathryn Bailey
Kjell Tullus
P2860
P304
P356
10.1002/ART.34410
P577
2012-07-01T00:00:00Z